Figure 1.
Toxicity after CD19 CAR T-cell reinfusion. (A) CRS grade by indication for CARTr according to the Penn scale. (B) Neurotoxicity grade by indication for CARTr according to the CTCAE 4.03 grading scale. (C) Proportion of patients who required inpatient admission within 30 days after CARTr by indication for CARTr. CTCAE, Common Terminology Criteria for Adverse Events.

Toxicity after CD19 CAR T-cell reinfusion. (A) CRS grade by indication for CARTr according to the Penn scale. (B) Neurotoxicity grade by indication for CARTr according to the CTCAE 4.03 grading scale. (C) Proportion of patients who required inpatient admission within 30 days after CARTr by indication for CARTr. CTCAE, Common Terminology Criteria for Adverse Events.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal